Insiders who reported open-market trades in the last 12 months at the companies Jason Pitofsky files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Christine A. Poon - $4.25M in REGN purchases and sales in the last 12 months
Marion McCourt - $2.00M in REGN purchases and sales in the last 12 months
Huda Y. Zoghbi - $1.92M in REGN purchases and sales in the last 12 months
Kathryn Guarini - $660K in REGN purchases and sales in the last 12 months
Bonnie L. Bassler - $570K in REGN purchases and sales in the last 12 months
Arthur F. Ryan - $435K in REGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jason Pitofsky is a corporate insider, tracked as SVP Controller of REGENERON PHARMACEUTICALS, INC. (REGN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jason Pitofsky last file a Form 4?
The most recent primary Form 4 on record is dated 11 February 2026, one of 4 filings going back to 2024.
Has Jason Pitofsky been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($1.87M) across all tracked filings.
Jason Pitofsky is SVP Controller of REGENERON PHARMACEUTICALS, INC. (REGN). 4 SEC Form 4 filings on record going back to 2024, most recently on 11 February 2026. Most recent open-market trade: sold $42K of REGN on 11 February 2026. Lifetime open-market sales: $1.87M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Jason Pitofsky.
InsiderAlpha's records for Jason Pitofsky go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. 13 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
